SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SYRA

Syra Health Corp (SYRA)

United States · Delayed Price · Currency is USD
Healthcare · Medical Care Facilities
0.90+0.01 (+1.53%)
 
Market cap
$10.7M
Insider Score
––Not scored
SYRA Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

SYRA Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue2.39 M2.27 M1.73 M1.69 M1.95 M1.86 M
Revenue Growth (YoY)23.03 %22.38 %-13.59 %-25.09 %-1.19 %6.02 %
Cost of Revenue1.33 M1.30 M1.14 M1.13 M1.19 M1.27 M
Gross Profit1.07 M971.25 K591.17 K554.54 K752.89 K589.16 K
SG&A Expense236.49 K772.30 K724.39 K780.50 K780.36 K1.02 M
R&D Expense47.35 K6.92 K139.00816.0029.71 K37.17 K
Operating Expenses814.73 K780.27 K726.83 K786.71 K816.05 K1.06 M
Operating Income251.57 K190.98 K-135.66 K-232.17 K-63.16 K-473.33 K
Pretax Income250.24 K240.98 K-134.57 K-225.90 K-63.60 K-472.26 K
Tax Provision0.000.000.000.000.000.00
Net Income250.24 K240.98 K-134.57 K-225.90 K-63.60 K-472.26 K
EPS (Basic)0.020.02-0.01-0.02-0.01-0.07
EPS (Diluted)0.020.02-0.01-0.02-0.01-0.07
Shares Outstanding13.18 M11.94 M11.94 M11.94 M11.94 M7.26 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.